Triton Therapeutics, Inc.
2 known investors
Clinical-stage company developing first-in-class medicines targeted at autoimmune and fibrotic diseases.
2 known investors
Clinical-stage company developing first-in-class medicines targeted at autoimmune and fibrotic diseases.